Atlas Trials

Safety and Tolerability of TG1050: A Dose-finding Study

Clinical trial NCT02428400 · COMPLETED

Trial details

NCT number
NCT02428400
Sponsor
Transgene
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Hepatitis B
Start date
2015-10-01
Primary completion
2018-11-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.